Your browser doesn't support javascript.
loading
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients.
Linardou, Helena; Lampaki, Sofia; Koliou, Georgia-Angeliki; Vozikis, Athanassios; Boutis, Anastasios; Nikolaidi, Adamantia; Kontogiorgos, Ioannis; Papakotoulas, Pavlos; Christopoulou, Athina; Spyratos, Dionysios; Bafaloukos, Dimitrios; Psyrri, Amanda; Grivas, Anastasios; Koumarianou, Anna; Tsiakitzis, Karyofyllis; Mauri, Davide; Rigakos, Georgios; Aravantinos, Gerasimos; Papantoniou, Panagiotis; Oikonomopoulos, Georgios; Fountzilas, Elena; Koufaki, Margarita-Ioanna; Kaparelou, Maria; Liolis, Elias; Mountzios, Giannis; Kosmidis, Paris; Fountzilas, George; Samantas, Epaminondas.
Afiliação
  • Linardou H; Fourth Oncology Department & Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece; elinardou@otenet.gr.
  • Lampaki S; Pulmonary Department, Lung Cancer Oncology Unit, Aristotle University of Thessaloniki, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece.
  • Vozikis A; Laboratory of Health Economics and Management, Economics Dept., University of Piraeus, Piraeus, Greece.
  • Boutis A; First Department of Clinical Oncology, Theagenio Hospital, Thessaloniki, Greece.
  • Nikolaidi A; Oncology Clinic, Mitera Hospital, Athens, Greece.
  • Kontogiorgos I; Laboratory of Health Economics and Management, Economics Dept., University of Piraeus, Piraeus, Greece.
  • Papakotoulas P; First Department of Clinical Oncology, Theagenio Hospital, Thessaloniki, Greece.
  • Christopoulou A; Medical Oncology Unit, S. Andrew Hospital, Patras, Greece.
  • Spyratos D; Pulmonary Department, Lung Cancer Oncology Unit, Aristotle University of Thessaloniki, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Bafaloukos D; First Department of Medical Oncology, Metropolitan Hospital, Athens, Greece.
  • Psyrri A; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Grivas A; Second Department of Internal Medicine, Agios Savvas Cancer Hospital, Athens, Greece.
  • Koumarianou A; Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Tsiakitzis K; Pharmacy Department, Aristotle University of Thessaloniki, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Mauri D; Department of Medical Oncology, Medical School, University of Ioannina, Ioannina, Greece.
  • Rigakos G; Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece.
  • Aravantinos G; Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece.
  • Papantoniou P; Laboratory of Health Economics and Management, Economics Dept., University of Piraeus, Piraeus, Greece.
  • Oikonomopoulos G; Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece.
  • Fountzilas E; Second Department of Medical Oncology, Euromedica General Clinic of Thessaloniki, Thessaloniki, Greece.
  • Koufaki MI; European University Cyprus, Engomi, Cyprus.
  • Kaparelou M; Laboratory of Health Economics and Management, Economics Dept., University of Piraeus, Piraeus, Greece.
  • Liolis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
  • Mountzios G; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece.
  • Kosmidis P; Fourth Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece.
  • Fountzilas G; Second Department of Medical Oncology, Hygeia Hospital, Athens, Greece.
  • Samantas E; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.
Anticancer Res ; 43(6): 2799-2812, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37247889
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: Europa Idioma: En Revista: Anticancer Res Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: Europa Idioma: En Revista: Anticancer Res Ano de publicação: 2023 Tipo de documento: Article